FCγ Chimeric Receptor-Engineered T Cells: Methodology, Advantages, Limitations, and Clinical Relevance

For many years, disappointing results have been generated by many investigations, which have utilized a variety of immunologic strategies to enhance the ability of a patient’s immune system to recognize and eliminate malignant cells. However, in recent years, immunotherapy has been used successfully...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Caratelli, Sara, Sconocchia, Tommaso, Arriga, Roberto, Coppola, Andrea, Lanzilli, Giulia, Lauro, Davide, Venditti, Adriano, Del Principe, Maria Ilaria, Buccisano, Francesco, Maurillo, Luca, Ferrone, Soldano, Sconocchia, Giuseppe
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2017
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5406408/
https://ncbi.nlm.nih.gov/pubmed/28496440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00457
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi